Sugar Free Product Details
Sugar free Cold-EEZE® LOZENGES are designed for health conscious consumers looking to limit their calorie and carbohydrate intake.
Sugar Free Cold-EEZE Lozenges contain Isomalt, a sugar alcohol, that contains about half the calories of sugar and other carbohydrates. Isomalt not a sugar replacement. It is called a sugar alcohol but does not contain any alcohol.
Sugar alcohols may raise blood glucose levels and are not recommended for people with Diabetes.
Diabetics should consult their health care professional before taking Cold-EEZE Sugar Free Lozenges. For more information on diabetic safe Cold-EEZE products, click here…
Each Sugar Free Cold-EEZE Lozenge contains:
- 2.24g of carbohydrates
- 9 calories
A daily dose of 6 lozenges contains:
- 13.44g of carbohydrates
- 54 calories
Cold-EEZE lozenges should be taken at the first sign of a cold, such as cough, sore throat, stuffy nose, sneezing, post-nasal drip and hoarseness. Continue treating with Cold-EEZE until all symptoms subside.
Cold-EEZE lozenges are all natural, contain no preservatives or dyes and are non-drowsy. Cold-EEZE is the #1 Pharmacist Recommended zinc cold treatment. It is recommended four-to-one over its nearest competitor.
For Persons with Diabetes, or Concern with Glycemic Control
Cold-EEZE Sugar-Free Tablets:
- Each box contains 48 Zinc Gluconate Glycine (ZIGGT) tablets.
- Each tablet contains 4.3 mg of Ionic Zinc.
- Flavor: Unflavored/unsweetened.
- Recommended daily dose: One tablet per hour, maximum of 16 daily.
- Clinically proven to be safe for people with diabetes.
Contains:
- 0 carbohydrates
- 0 calories
From the Diabetes and Glandular Disease Clinic Study, San Antonio, Texas
A single-center, randomized, single-blind placebo-controlled trial was conducted in patients with diabetes to assess the effects of sugar-free Cold-EEZE tablets on glucose control in patients maintained on stable antidiabetic therapy.
Results
- No detrimental effect on overall diabetic control.
Adverse Events:
- No patients withdrew from the trial. There were no serious adverse events.